EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA

BACKGROUND: Medulloblastoma (MB) is one of the most common malignant pediatric CNS tumors. Patients with Group 3 MBs harboring MYC amplification exhibit low survival rates. Surviving patients suffer from therapy-induced sequelae, which calls for new targeted therapy strategies. We and others have pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Valinciute, Gintvile, Ecker, Jonas, Selt, Florian, Hielscher, Thomas, Schmidt, Christin, Sigaud, Romain, Ridinger, Johannes, Gatzweiler, Charlotte, Picard, Daniel, Oppermann, Sina, Blattner-Johnson, Mirjam, Jones, David T W, Oehme, Ina, Kool, Marcel, Remke, Marc, Pfister, Stefan M, Witt, Olaf, Milde, Till
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Embryonal Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168241/
http://dx.doi.org/10.1093/neuonc/noab090.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168241/
http://dx.doi.org/10.1093/neuonc/noab090.019

Ejemplares similares